[HTML][HTML] Targeting PI3K/Akt signal transduction for cancer therapy

Y He, MM Sun, GG Zhang, J Yang, KS Chen… - Signal transduction and …, 2021 - nature.com
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays a crucial role in various
cellular processes and is aberrantly activated in cancers, contributing to the occurrence and …

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

JA Engelman - Nature Reviews Cancer, 2009 - nature.com
There are ample genetic and laboratory studies that suggest the PI3K–Akt pathway is vital to
the growth and survival of cancer cells. Inhibitors targeting this pathway are entering the …

Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy

YL Chen, PY Law, HH Loh - Current Medicinal Chemistry-Anti …, 2005 - ingentaconnect.com
The phosphatidylinositol 3-kinase (PI3K)/Akt (protein kinase B, PKB) signaling pathway
plays a critical role in cell growth and survival. Dysregulation of this pathway has been found …

Targeting the PI3K signaling pathway in cancer therapy

C Bartholomeusz… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: The PI3K signaling pathway is involved in the regulation of cancer cell growth,
motility, survival and metabolism. The pathway is frequently active in many different types of …

Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy

NT Ihle, G Powis - Molecular cancer therapeutics, 2009 - AACR
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is currently one of
the most exciting drug targets in oncology. However, only a short time ago, the paradigm …

The PI3K pathway as drug target in human cancer

KD Courtney, RB Corcoran… - Journal of clinical oncology, 2010 - ascopubs.org
The phosphatidylinositol 3-kinase (PI3K) signaling axis impacts on cancer cell growth,
survival, motility, and metabolism. This pathway is activated by several different mechanisms …

[HTML][HTML] Targeting PI3K in cancer: mechanisms and advances in clinical trials

J Yang, J Nie, X Ma, Y Wei, Y Peng, X Wei - Molecular cancer, 2019 - Springer
Abstract Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR)
signaling is one of the most important intracellular pathways, which can be considered as a …

PI3K/AKT signaling pathway and cancer: an updated review

M Martini, MC De Santis, L Braccini, F Gulluni… - Annals of …, 2014 - Taylor & Francis
Despite development of novel agents targeting oncogenic pathways, matching targeted
therapies to the genetic status of individual tumors is proving to be a daunting task for …

Targeting the phosphoinositide 3-kinase pathway in cancer

P Liu, H Cheng, TM Roberts, JJ Zhao - Nature reviews Drug discovery, 2009 - nature.com
Abstract The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system
that links oncogenes and multiple receptor classes to many essential cellular functions, and …

At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy

N Vasan, LC Cantley - Nature Reviews Clinical Oncology, 2022 - nature.com
Numerous agents targeting various phosphatidylinositol 3-kinase (PI3K) pathway
components, including PI3K, AKT and mTOR, have been tested in oncology clinical trials …